When Zentalis Pharmaceuticals, Inc. reports, what it reported each quarter, and how the stock took the results.
31 quarters. Mar 31, 2019 to Sep 30, 2026. USD.
Mar 25, after the close
Thu, Mar 25, 2027in 126 days
Projected from its last 8 releases. The company has not named the day yet.
| Period | Ended | Announced | Filed | Lag | Form |
|---|
Zentalis Pharmaceuticals, Inc. · CIK 1725160 · Engraved from SEC EDGAR
| Revenue |
|---|
| Δ yoy |
|---|
| EPS dil. |
|---|
| Move |
|---|
| Source trail |
|---|
| FY 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | Nov 9, 2026 · after-hours | Nov 9, 2026 | 40 d | 10-Q | — | — | -$0.34 | — | |
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | — | — | -$0.59 | 15.7% | |
| Q1 2026 | Mar 31, 2026 | May 12, 2026 · after-hours | May 12, 2026 | 42 d | 10-Q | — | — | -$0.50 | +0.4% | |
| FY 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 26, 2026 · after-hours | Mar 26, 2026 | 85 d | 10-K | $0.00 | −100.0% | — | 21.6% | |
| Q3 2025 | Sep 30, 2025 | Nov 10, 2025 · after-hours | Nov 10, 2025 | 41 d | 10-Q | $0.00 | — | -$0.37 | +5.7% | |
| Q2 2025 | Jun 30, 2025 | Aug 6, 2025 · after-hours | Aug 6, 2025 | 37 d | 10-Q | $0.00 | — | -$0.37 | +5.8% | |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 · after-hours | May 14, 2025 | 44 d | 10-Q | $0.00 | −100.0% | -$0.67 | +5.9% | |
| FY 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 26, 2025 · after-hours | Mar 26, 2025 | 85 d | 10-K | $26.87M | — | — | +1.4% | |
| Q3 2024 | Sep 30, 2024 | — | Nov 12, 2024 | 43 d | 10-Q | $0.00 | — | -$0.56 | +5.7% | |
| Q2 2024 | Jun 30, 2024 | Aug 9, 2024 · pre-market | Aug 9, 2024 | 40 d | 10-Q | $0.00 | — | -$1.24 | — | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · pre-market | May 7, 2024 | 37 d | 10-Q | $40.56M | — | $0.14 | +6.1% | |
| FY 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 27, 2024 · pre-market | Feb 27, 2024 | 58 d | 10-K | $0.00 | — | — | +4.5% | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · pre-market | Nov 6, 2023 | 37 d | 10-Q | $0.00 | — | -$0.79 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 9, 2023 · pre-market | Aug 9, 2023 | 40 d | 10-Q | $0.00 | — | -$1.85 | +0.7% | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · pre-market | May 10, 2023 | 40 d | 10-Q | $0.00 | — | -$1.07 | +6.9% | |
| FY 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 1, 2023 · pre-market | Mar 1, 2023 | 60 d | 10-K | — | — | — | 0.3% | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · pre-market | Nov 9, 2022 | 40 d | 10-Q | — | — | -$0.96 | — | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | — | — | -$1.34 | 8.6% | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · pre-market | May 5, 2022 | 35 d | 10-Q | — | — | -$1.31 | 16.1% | |
| FY 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Dec 31, 2021 | Feb 24, 2022 · pre-market | Feb 24, 2022 | 55 d | 10-K | — | — | -$1.11 | +3.1% | |
| Q3 2021 | Sep 30, 2021 | Nov 10, 2021 · pre-market | Nov 10, 2021 | 41 d | 10-Q | — | — | -$0.09 | — | |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 · pre-market | Aug 12, 2021 | 43 d | 10-Q | — | — | -$1.34 | 5.2% | |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 · pre-market | May 17, 2021 | 47 d | 10-Q | — | — | -$1.24 | 6.5% | |
| FY 2020 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Mar 25, 2021 · pre-market | Mar 25, 2021 | 84 d | 10-K | — | — | -$1.01 | 5.6% | |
| Q3 2020 | Sep 30, 2020 | Nov 9, 2020 · pre-market | Nov 9, 2020 | 40 d | 10-Q | — | — | -$0.91 | 8.7% | |
| Q2 2020 | Jun 30, 2020 | Aug 13, 2020 · pre-market | Aug 13, 2020 | 44 d | 10-Q | — | — | -$0.78 | +1.0% | |
| Q1 2020 | Mar 31, 2020 | May 15, 2020 · pre-market | May 15, 2020 | 45 d | 10-Q | — | — | -$2.88 | 5.5% | |
| FY 2019 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | — | — | — | — | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | — | — | — | — | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | — | — | — | — | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | -$1.49 | — | |
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −21.6% after Q4 2025.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.